Evaluation of diffusion-weighted imaging as a predictive marker for tumor response in patients undergoing chemoradiation for postoperative recurrences of cervical cancer

Journal of Cancer Research and Therapeutics

Volumn 8, Issue 1, 2012, Pages 68-73

  Chopra, Supriya ^a   Verma, Ashish ^a   Kundu, Sayan ^a   Engineer, Reena ^a   Medhi, Seema ^a   Mahantshetty, Umesh ^a   Gupta, Sudeep ^a   Shrivastava, Shyam K ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cervical cancer; diffusion weighted imaging; MRI; postoperative; recurrent

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

ADULT; AGED; CHEMORADIOTHERAPY; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROGNOSIS; ROC CURVE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84860477066     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.95177     Document Type: Article

References (17)

1. Piura B, Rabinovich A, Friger M. Recurrent cervical carcinoma after radical hysterectomy and pelvic lymph node dissection: A study of 32 cases. Eur J Gynaecol Oncol 2008;29:31-6. (Pubitemid 351344758)
2. Mahantshelly U, Banerjee S, Chopra S, Engineer R, Shrivastava SK. Clinical outcome of patients treated with template based high dose rate (HDR) interstitial brachytherapy boost in gynecological malignancies. Radiother Oncol 2011;99:S117.
3. Monk BJ, Walker JL, Tewari K, Ramsinghani NS, Syed AM, DiSaia PJ. Open Interstitial Brachytherapy for the Treatment of Local-Regional Recurrences of Uterine Corpus and Cervix Cancer after Primary Surgery. J Gynecol Oncol 1994;52:222-8. (Pubitemid 24064374)
4. Reesink-Peters N, van der Velden J, ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, et al. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. J Clin Oncol 2005;23:1455-62.
5. Liu Y, Bai R, Sun H, Liu H, Zhao X, Li Y. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol 2009;64:1067-74.
6. Harry VN, Semple SI, Gilbert FJ, Parkin DE. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008;111:213-20.
7. McVeigh P, Syed A, Milosevic M, Fyles A, Haider M. Diffusion-weighted MRI in cervical cancer. Eur Radiol 2008;18:1058-64.
8. Payne GS, Schmidt M, Morgan VA, Giles S, Bridges J, Ind T, et al. Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer. Gynecol Oncol 2010;116:246-52.
9. Koh DM, Collins DJ. Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology. AJR Am J Roentgenol 2007;188:1622-35. (Pubitemid 46866868)
10. Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006;24:843-7. (Pubitemid 44205378)
11. Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: Preliminary results. Int J Radiat Oncol Biol Phys 2012;82:863-70.
12. Dong S, Ye XD, Yuan Z, Xu LC, Xiao XS. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization. Eur J Radiol 2012;81:472-7.
13. Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Poorten VV, Hauben E, et al. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012;82: 1098-107.
14. Nilsen L, Fangberget A, Geier O, Olsen DR, Seierstad T. Diffusionweighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010;49:354-60.
15. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828-36. (Pubitemid 30387603)
16. Vandecaveye V, De Keyzer F, Nuyts S, Deraedt K, Dirix P, Hamaekers P, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: Correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007;67:960-71.
17. MR-PET Guided Biologically Optimised Interstitial Brachytherapy. Available from: http://clinicaltrials.gov. [Last Accessed on 2011 Jul 10].